Drug Profile
IMD 0354
Alternative Names: IMD-0354Latest Information Update: 28 May 2013
Price :
$50
*
At a glance
- Originator Institute of Medicinal Molecular Design
- Class Small molecules
- Mechanism of Action I-kappa B kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Atopic dermatitis
Most Recent Events
- 28 May 2013 IMD 0354 is available for licensing as of 01 May 2009. http://www.immd.co.jp
- 28 May 2013 No development reported - Phase-I for Atopic dermatitis in Hong Kong (Topical)